Device Trial Radar · NCT01065948
A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours
Last checked: Nov 19, 2026Latest source record: Feb 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Nov 2009
Primary completion
Jun 2012
Study completion Aug 2012
Sponsor
- Lead sponsor
- BioTex, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Endocrinoloogy Associates Houston
- First posted
- Feb 10, 2010
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical research study is to learn about a new minimally invasive glucose monitoring device called Fluorescence Affinity Sensor (FAS). In this study, the FAS will be used to determine its effectiveness for glucose monitoring. Researchers want to find out how the device performs at two different body sites (forearm and abdomen) over 4 hours. The safety and comfort level of the device will also be studied.
Conditions
- Diabetes
Interventions
Subcutaneous glucose monitoring deviceDevice
monitor interstitial glucose level every 5 min over 4 hours
Primary outcomes
What the sponsor says the trial is designed to measure.
- examine accuracy of FAS response to glucose changes in subcutaneous tissue (compared to blood glucose concentrations measured with reference method)Time frame: 3 months
- monitor safety and performance of FAS response in two different body sites (abdomen, forearm)Time frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Practice of Eric Orzeck, MD
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.